PL2220082T3 - Trwała sól krystaliczna estru 1-azabicyklo[2.2.2]okt-3-ylowego kwasu (r)-3-fluorofenylo-3,4,5-trifluorobenzylokarbaminowego - Google Patents

Trwała sól krystaliczna estru 1-azabicyklo[2.2.2]okt-3-ylowego kwasu (r)-3-fluorofenylo-3,4,5-trifluorobenzylokarbaminowego

Info

Publication number
PL2220082T3
PL2220082T3 PL08854867T PL08854867T PL2220082T3 PL 2220082 T3 PL2220082 T3 PL 2220082T3 PL 08854867 T PL08854867 T PL 08854867T PL 08854867 T PL08854867 T PL 08854867T PL 2220082 T3 PL2220082 T3 PL 2220082T3
Authority
PL
Poland
Prior art keywords
azabiciyclo
fluorophenyl
oct
ester
crystalline salt
Prior art date
Application number
PL08854867T
Other languages
English (en)
Inventor
Ruiz Juan Lorenzo Catena
Rodriguez José Hidalgo
Comas Maria Del Carmen Serra
Masip Isabel Masip
Original Assignee
Salvat Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvat Lab Sa filed Critical Salvat Lab Sa
Publication of PL2220082T3 publication Critical patent/PL2220082T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL08854867T 2007-11-28 2008-11-26 Trwała sól krystaliczna estru 1-azabicyklo[2.2.2]okt-3-ylowego kwasu (r)-3-fluorofenylo-3,4,5-trifluorobenzylokarbaminowego PL2220082T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07384038A EP2065385A1 (en) 2007-11-28 2007-11-28 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
PCT/EP2008/010012 WO2009068253A2 (en) 2007-11-28 2008-11-26 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
EP08854867.2A EP2220082B1 (en) 2007-11-28 2008-11-26 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester

Publications (1)

Publication Number Publication Date
PL2220082T3 true PL2220082T3 (pl) 2014-12-31

Family

ID=39401152

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08854867T PL2220082T3 (pl) 2007-11-28 2008-11-26 Trwała sól krystaliczna estru 1-azabicyklo[2.2.2]okt-3-ylowego kwasu (r)-3-fluorofenylo-3,4,5-trifluorobenzylokarbaminowego

Country Status (19)

Country Link
US (2) US8492402B2 (pl)
EP (2) EP2065385A1 (pl)
JP (1) JP5336509B2 (pl)
KR (1) KR101557832B1 (pl)
CN (1) CN101925600B (pl)
AU (1) AU2008329181B2 (pl)
BR (1) BRPI0819607A2 (pl)
CA (1) CA2706565C (pl)
DK (1) DK2220082T3 (pl)
EA (1) EA017483B1 (pl)
ES (1) ES2498819T3 (pl)
HK (1) HK1144192A1 (pl)
IL (1) IL206032A (pl)
MX (1) MX2010005850A (pl)
NZ (1) NZ585833A (pl)
PL (1) PL2220082T3 (pl)
UA (1) UA102083C2 (pl)
WO (1) WO2009068253A2 (pl)
ZA (1) ZA201003718B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1345937T3 (da) 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
PT3150610T (pt) 2010-02-12 2019-11-11 Pfizer Sais e polrmorfos de 8-fluor0-2-{4- [(metilamino}metil]fenil}-1,3,4,5-tetrahidr0-6hazepin0[ 5,4,3-cd]indol-6-0na
KR101978364B1 (ko) 2017-06-15 2019-05-14 크리스탈지노믹스(주) 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
PT1300407E (pt) * 2000-06-27 2004-05-31 S A L V A T Lab Sa Compostos carbamatos derivados de arilalquilaminas
DK1345937T3 (da) * 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
US7452904B2 (en) 2001-12-20 2008-11-18 Chiesi Farmaceutici S.P.A. 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.

Also Published As

Publication number Publication date
US20110207769A1 (en) 2011-08-25
KR20100103532A (ko) 2010-09-27
CN101925600B (zh) 2013-01-09
EA017483B1 (ru) 2012-12-28
IL206032A0 (en) 2010-11-30
US8871787B2 (en) 2014-10-28
CA2706565C (en) 2015-04-28
UA102083C2 (uk) 2013-06-10
DK2220082T3 (da) 2014-10-06
IL206032A (en) 2014-07-31
EA201070651A1 (ru) 2010-12-30
WO2009068253A2 (en) 2009-06-04
US20140051721A1 (en) 2014-02-20
BRPI0819607A2 (pt) 2015-10-13
AU2008329181A1 (en) 2009-06-04
CN101925600A (zh) 2010-12-22
US8492402B2 (en) 2013-07-23
AU2008329181B2 (en) 2012-03-29
JP2011504890A (ja) 2011-02-17
EP2220082B1 (en) 2014-06-25
ES2498819T3 (es) 2014-09-25
CA2706565A1 (en) 2009-06-04
MX2010005850A (es) 2010-09-03
ZA201003718B (en) 2011-08-31
NZ585833A (en) 2011-05-27
EP2065385A1 (en) 2009-06-03
WO2009068253A3 (en) 2009-08-13
EP2220082A2 (en) 2010-08-25
HK1144192A1 (en) 2011-02-02
KR101557832B1 (ko) 2015-10-06
JP5336509B2 (ja) 2013-11-06

Similar Documents

Publication Publication Date Title
HK1209628A1 (en) Methods, compounds, compositions and vehicles for delivering 3-amino- 1-propanesulfonic acid 3--1-
PT2350075E (pt) Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2009083940A3 (en) Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
ZA200905832B (en) Crystalline forms of an 8-azabicyclo [3.2.1] octane compound
AU2008287784A1 (en) Phenylacetic acid compound
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
ZA201107412B (en) Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
PL2213669T3 (pl) Krystaliczna pochodna kwasu imidazolo-5-karboksylowego
IL225557A0 (en) Method for preparing (3s,3s') 4,4'-disulfanedilbis (3-aminobutane 1- sulfonic acid)
WO2009037538A3 (en) Process for the preparation of lamivudine form i
HK1144192A1 (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222]
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same
IL213171A (en) Composition for producing trans-2,2 dimethyl 3-formylcyclopropanecarboxylic acid ester
WO2011058521A3 (en) Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
EP2077994A4 (en) CRYSTALLINE WATER-FREE S - (-) - AMLODIPINADIPINIC ACID SALT AND METHOD FOR THE PRODUCTION THEREOF
EP1896487A4 (en) PROCESS FOR THE PREPARATION OF OXABISPIDINE SULFONIC ACID SALTS
EP2468879A4 (en) A-87774 COMPOUND OR SALT THEREOF, METHOD FOR THE PRODUCTION OF THE COMPOUND OR THE SALT, AND AGRICULTURAL CHEMICALS WITH THE COMPOUND OR THE SALT THEREOF AS ACTIVE SUBSTANCE
EP2053032A4 (en) METHOD FOR PRODUCING AN OPTICALLY ACTIVE HYDROXYCARBOXYLENE DERIVATIVE OR SALT THEREOF
AU2007905798A0 (en) alpha-Cyclopropyl-alpha-Amino Carboxylic Acid Compounds and Methods for their Preparation
AU2007904276A0 (en) Acid sulphate soil treatment